collaboration

EPSRC – Deadline: 13 Mar 2018

Interdisciplinary Research Collaboration (IRC) in Targeted Therapeutic Delivery

 

Following the outline expert panel in December 2017, EPSRC‘s Healthcare Technologies theme has invited selected proposals to submit a full application for an ‘Interdisciplinary Research Collaboration (IRC) in Targeted Therapeutic Delivery Technologies’ in September 2017. It is anticipated that a budget of up to £10 million will be available to support one IRC for five to seven years.

Potential applicants can now approach either AstraZeneca (AZ) or GlaxoSmithKline (GSK) if they wish to help develop the full proposal

There will be no obligation on applicants to partner with AZ or GSK (and vice versa). Nor is this intended to preclude partnership with other project partners, including other businesses.

Each bid is expected to consist of one lead institution, with a number of collaborative institutions that bring together world leading research expertise in the disciplines required to deliver the breadth of research proposed.

Collaborations are expected to undertake basic engineering and physical sciences research that assumes a holistic approach to the challenges of developing technologies for targeted therapeutic delivery. Collaborations should have a clear vision for the research and how their approach can contribute to transforming Targeted Therapeutic Delivery Technologies. These should include (but are not limited to):

  • Designing and creating novel formulations
  • Characterising the drug vehicle
  • Manufacturing of novel therapeutic medicine (ideally with renewable materials and at affordable costs)
  • Engineering and Physical Sciences for mediated drug delivery, for example encapsulation, magnetic, ultrasonic and photodynamic approaches
  • Characterisation, metrology and activation of targeted therapies in humans

The call primarily aims to support targeted delivery of medicines, from nanomedicines to large molecules, rather than non-medicinal interventions. Therefore surgeries, radiotherapies and other similar approaches are outside the scope of this call. In addition, because regenerative therapies are covered by the UK Regenerative Medicine Platform, we do not expect the delivery of advanced/regenerative therapies to form a significant focus of the IRC in Targeted Therapeutic Delivery Technologies.

There are some overarching principles which applicants should be aware of:

  • The majority of the research should be within the scientific remit of EPSRC.
  • The application should have one lead institution and typically several collaborative institutions;
  • An institution may only lead on one bid but may partner in others;
  • EPSRC does not accept resubmissions;
  • The application must be collaborative and multi-disciplinary in nature. The expectation is to bring together relevant disciplines and users to further the research challenges of this area;
  • Full proposals will be expected to demonstrate evidence of user buy-in to the collaboration

Following the initial outline stage of this call, selected proposals have been invited to submit a full proposal. The full proposal will be assessed by postal peer review and then an expert interview panel. Full guidance on the preparation of outline and details of the assessment process, can be found in the call document.

For more information please visit the EPSRC website.

Advertisements

Wellcome Trust – Deadline: 24 Apr 2018

Collaborative Awards in Science

Collaborative Awards promote the development of new ideas and speed the pace of discovery. We fund teams of researchers, consisting of independent research groups, to work together on the most important scientific problems that can only be solved through collaborative efforts.

Applications for this scheme are usually considered two times a year (April and November).

for more information please visit the Wellcome Trust website.